Literature DB >> 18410904

Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma.

Adam Bryant, Sam Milliken.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18410904     DOI： 10.1016/j.bbmt.2008.01.010

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  11 in total

Review 1.  Current status of treatment for primary effusion lymphoma.

Authors:  Seiji Okada; Hiroki Goto; Mihoko Yotsumoto
Journal:  Intractable Rare Dis Res       Date:  2014-08

Review 2.  Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

Authors:  Shukaib Arslan; Mark R Litzow; Nathan W Cummins; Stacey A Rizza; Andrew D Badley; Willis Navarro; Shahrukh K Hashmi
Journal:  Biol Blood Marrow Transplant       Date:  2019-03-26       Impact factor: 5.742

3.  Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; Mi Kwon; Gabriela Rodriguez-Macias; Jorge Gayoso; Javier Anguita; Ismael Buño; Juan Berenguer; José L Díez-Martín
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

4.  HIV and Stem Cell Transplantation.

Authors:  Ignacio A Echenique; George E Nelson; Valentina Stosor; Christine M Durand
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

Review 5.  Hematopoietic stem cell transplantation in patients infected with HIV.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; José Luis Díez-Martin; Juan Berenguer
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 6.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.

Authors:  G Hütter; J A Zaia
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

7.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

8.  Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.

Authors:  Vikas Gupta; Marcie Tomblyn; Tanya L Pedersen; Harry L Atkins; Minoo Battiwalla; Ronald E Gress; Marilyn S Pollack; Jan Storek; Jill C Thompson; Pierre Tiberghien; Jo-Anne H Young; Patricia Ribaud; Mary M Horowitz; Armand Keating
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

9.  Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.

Authors:  A Antar; H El Hajj; M Jabbour; I Khalifeh; F El-Merhi; R Mahfouz; A Bazarbachi
Journal:  Blood Cancer J       Date:  2014-03-07       Impact factor: 11.037

10.  Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

Authors:  Marion Gruffaz; Shenghua Zhou; Karthik Vasan; Teresa Rushing; Qing Liu Michael; Chu Lu; Jae U Jung; Shou-Jiang Gao
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.